Prestige Consumer Healthcare Inc. (PBH) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Prestige Consumer Healthcare Inc. (PBH) closed at USD 49.20 on 2026-10-15, a change of -19 % over the past year, with a market capitalization of USD 2.36B.

Prestige Consumer Healthcare Inc. recent closing prices

DateClose (USD)
2026-10-1549.20
2026-10-1448.40
2026-10-1348.50
2026-10-1249.00
2026-10-0948.23
2026-10-0847.87
2026-10-0747.57

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Prestige Consumer Healthcare Inc. key figures

Previous close
USD 49.20 (2026-10-15)
1-year change
-19 %
Market cap
USD 2.36B
Enterprise value
USD 4.34B
P/E ratio (trailing)
13.98
P/E ratio (forward)
9.82
EPS (trailing)
3.57
EPS (forward)
5.08
PEG ratio
1.55
Price to book
1.23
Revenue growth
6.5 %
Earnings growth
-35.8 %
Dividend per share (trailing)
0.00
Short ratio
7.69
Employees
890
Analyst consensus (third-party)
none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Prestige Consumer Healthcare Inc. and compare it with other stocks.

Analyze PBHAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Prestige Consumer Healthcare Inc. shares.